Literature DB >> 3456741

Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern.

E E Vanderveen, R C Grekin, N A Swanson, K Kragballe.   

Abstract

There is evidence suggesting a role of eicosanoids in the growth of certain tumors. In this study, tissue samples were collected from basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) of the skin. Both BCCs and SCCs contained more prostaglandin E2 and F2 alpha (PGE2 and PGF2 alpha) than normal epidermis. In vitro incubation of tumor samples with arachidonic acid also resulted in PGE2 and PGF2 alpha formation. Basal cell carcinomas exhibiting a histologically aggressive growth pattern contained higher levels of prostaglandins than those with a nonaggressive growth pattern, both in vivo and after in vitro incubation. Lipoxygenase products (12- and 15-hydroxyeicosatetraenoic acid) were present in smaller amounts than cyclo-oxygenase products (PGE2 and PGF2 alpha) in vivo. Compared with normal epidermis, SCCs and, particularly, BCCs produced smaller amounts of 12-hydroxyeicosatetraenoic acid during in vitro incubation with arachidonic acid. The levels of lipoxygenase products were not related to the tumor growth pattern. These results indicate that excessive prostaglandin levels in BCCs may be associated with an aggressive growth pattern.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456741     DOI: 10.1001/archderm.122.4.407

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  19 in total

1.  Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancer.

Authors:  I Klapan; V Katić; F Culo; V Cuk
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Intake of omega-3 and omega-6 fatty acids and risk of basal and squamous cell carcinomas of the skin: a longitudinal community-based study in Australian adults.

Authors:  Sarah C Wallingford; Josephina A van As; Maria Celia Hughes; Torukiri I Ibiebele; Adèle C Green; Jolieke C van der Pols
Journal:  Nutr Cancer       Date:  2012-09-13       Impact factor: 2.900

3.  The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1.

Authors:  E J Thompson; A Gupta; G A Vielhauer; J W Regan; G T Bowden
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

4.  Dietary grape seed proanthocyanidins inhibit UVB-induced cyclooxygenase-2 expression and other inflammatory mediators in UVB-exposed skin and skin tumors of SKH-1 hairless mice.

Authors:  Som D Sharma; Santosh K Katiyar
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

5.  A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice.

Authors:  J Andrews; G M Halliday; H K Muller
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 6.  Dietary proanthocyanidins inhibit UV radiation-induced skin tumor development through functional activation of the immune system.

Authors:  Santosh K Katiyar
Journal:  Mol Nutr Food Res       Date:  2016-04-13       Impact factor: 5.914

7.  IL-12 deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz(a)anthracene-initiated mouse skin through inhibition of inflammation.

Authors:  Som D Sharma; Syed M Meeran; Nandan Katiyar; George B Tisdale; Nabiha Yusuf; Hui Xu; Craig A Elmets; Santosh K Katiyar
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

Review 8.  Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms.

Authors:  Joi A Nichols; Santosh K Katiyar
Journal:  Arch Dermatol Res       Date:  2009-11-07       Impact factor: 3.017

9.  Production of prostaglandin E by squamous carcinoma of the head and neck and adenocarcinoma of gastrointestinal tissue.

Authors:  F Culo; I Klapan; V Katić; T Kolak; B Bakula
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

10.  Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.

Authors:  Heather L Chandler; Curtis A Barden; Ping Lu; Donna F Kusewitt; Carmen M H Colitz
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.